

Innovation in Connectivity Roundtable: Presentations
Information
The first part of our Innovation in Connectivity Roundtable features a series of presentations from Nemera, D4P Pharma and xTag.
Patient Journey Driven Considerations for Integrating Digital Health for Combination Products
- The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative.
- Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health.
- Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products.
Mark Tunkel, Global Category Director for Insight Innovation, Nemera
Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired
- The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients.
- The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients.
- Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information.
Laurent Tonnelier, CEO, mobiLead - xTag
Lise Wagner, Accessibility Specialist and User Expert, OKEENEA
Traceability of Medicines: from Finished Product to Unit Dose Delivery
- Challenges for B2B Supply Chain stakeholders
- Regulations: a global overview
- What about B2C
Nathalie Wardé, CEO & Founder, D4P pharma
Innovation in Connectivity Roundtable: Presentations
Innovation in Connectivity Roundtable: Live Discussion and Q&A
Nathalie Wardé · D4P-Pharma
Mark Tunkel · Nemera


